ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis.

X Gao; Yu-Wen Wen; JJB van Lanschot; YK Chao

doi:10.1245/s10434-021-11286-2

ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis.

X Gao
, Yu-Wen Wen
, JJB van Lanschot
, YK Chao

Department of Biomedical Sciences (Master's Program in Clinical Trials Assessment)

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	Annals of Surgical Oncology
Volume	29
Issue number	6
DOIs	https://doi.org/10.1245/s10434-021-11286-2
State	Published - 2022

Access to Document

10.1245/s10434-021-11286-2

Cite this

@article{036397fefabf48f7a1e9ecb34a565226,

title = "ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis.",

author = "X Gao and Yu-Wen Wen and \{van Lanschot\}, JJB and YK Chao",

year = "2022",

doi = "10.1245/s10434-021-11286-2",

language = "American English",

volume = "29",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "6",

}

TY - JOUR

T1 - ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis.

AU - Gao, X

AU - Wen, Yu-Wen

AU - van Lanschot, JJB

AU - Chao, YK

PY - 2022

Y1 - 2022

U2 - 10.1245/s10434-021-11286-2

DO - 10.1245/s10434-021-11286-2

M3 - Journal Article

C2 - 35152359

SN - 1068-9265

VL - 29

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 6

ER -